
Reset all filters
01 4Pfizer Consumer Healthcare
02 28Pfizer Inc
03 2Pinnacle Life Science
04 2Pluviaendo
Reset all filters
01 2CAP
02 2CAPSULE
03 3CAPSULE, PELLETS;ORAL
04 2CAPSULE;ORAL
05 7Capsule
06 2Capsule, hard
07 2Capsules
08 1Crizotinib 200Mg 60 Units Oral Use
09 1Crizotinib 250Mg 60 Units Oral Use
10 3Granule In Capsule
11 3Granules
12 4Hard Capsule
13 4capsule
Reset all filters
01 5Allowed
02 5Approved
03 5Authorized
04 2Originator
05 2Prescription
06 5RX
07 12Blank
Reset all filters
01 2Crizotinib
02 7XALKORI
03 23Xalkori
04 1Xalkori 200mg
05 1Xalkori 250mg
06 2Blank
Reset all filters
01 4Australia
02 2Canada
03 2India
04 2Italy
05 2Norway
06 2South Africa
07 5Spain
08 5Sweden
09 5Switzerland
10 2Turkey
11 5USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XALKORI
Dosage Form : CAPSULE;ORAL
Dosage Strength : 200MG
Packaging :
Approval Date : 2011-08-26
Application Number : 202570
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XALKORI
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2011-08-26
Application Number : 202570
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XALKORI
Dosage Form : CAPSULE, PELLETS;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2023-09-07
Application Number : 217581
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XALKORI
Dosage Form : CAPSULE, PELLETS;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2023-09-07
Application Number : 217581
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XALKORI
Dosage Form : CAPSULE, PELLETS;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date : 2023-09-07
Application Number : 217581
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Xalkori
Dosage Form : Crizotinib 200Mg 60 Units Oral Use
Dosage Strength : 60 cps 200 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Xalkori
Dosage Form : Crizotinib 250Mg 60 Units Oral Use
Dosage Strength : 60 cps 250 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Xalkori
Dosage Form : Capsule, hard
Dosage Strength : 200 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Xalkori
Dosage Form : Capsule, hard
Dosage Strength : 250 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Xalkori
Dosage Form : Hard Capsule
Dosage Strength : 200mg
Packaging :
Approval Date : 05/03/2012
Application Number : 62131
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Xalkori
Dosage Form : Hard Capsule
Dosage Strength : 250mg
Packaging :
Approval Date : 05/03/2012
Application Number : 62131
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Xalkori
Dosage Form : Granules
Dosage Strength : 20mg
Packaging :
Approval Date : 29/08/2024
Application Number : 69467
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Xalkori
Dosage Form : Granules
Dosage Strength : 50mg
Packaging :
Approval Date : 29/08/2024
Application Number : 69467
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Xalkori
Dosage Form : Granules
Dosage Strength : 150mg
Packaging :
Approval Date : 29/08/2024
Application Number : 69467
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Xalkori
Dosage Form : Capsule
Dosage Strength : 150mg
Packaging :
Approval Date : 22/08/2024
Application Number : 20230530000124
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Xalkori
Dosage Form : Capsule
Dosage Strength : 20mg
Packaging :
Approval Date : 22/08/2024
Application Number : 20230530000100
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : India
Brand Name : Crizotinib
Dosage Form : Capsules
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Crizotinib
Dosage Form : Capsules
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Turkey
Brand Name :
Dosage Form : Capsule
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name :
Dosage Form : Capsule
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey